Use of Integrated Computational Approaches in the Search for New Therapeutic Agents

Computer‐aided drug discovery plays a strategic role in the development of new potential therapeutic agents. Nevertheless, the modeling of biological systems still represents a challenge for computational chemists and at present a single computational method able to face such challenge is not available. This prompted us, as computational medicinal chemists, to develop in‐house methodologies by mixing various bioinformatics and computational tools. Importantly, thanks to multi‐disciplinary collaborations, our computational studies were integrated and validated by experimental data in an iterative process. In this review, we describe some recent applications of such integrated approaches and how they were successfully applied in i) the search of new allosteric inhibitors of protein‐protein interactions and ii) the development of new redox‐active antimalarials from natural leads.

[1]  Oliver F. Lange,et al.  Recognition Dynamics Up to Microseconds Revealed from an RDC-Derived Ubiquitin Ensemble in Solution , 2008, Science.

[2]  S. Parapini,et al.  Further optimization of plakortin pharmacophore: structurally simple 4-oxymethyl-1,2-dioxanes with promising antimalarial activity. , 2013, European journal of medicinal chemistry.

[3]  M. Zacharias,et al.  Substrate Binding Specifically Modulates Domain Arrangements in Adenylate Kinase. , 2015, Biophysical journal.

[4]  Benedetta Mennucci,et al.  Perspective: Polarizable continuum models for quantum-mechanical descriptions. , 2016, The Journal of chemical physics.

[5]  Olivier Sperandio,et al.  One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade. , 2013, Drug discovery today.

[6]  Nagi Ayad,et al.  Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4 , 2015, Scientific Reports.

[7]  Julien Michel,et al.  Current and emerging opportunities for molecular simulations in structure-based drug design , 2014, Physical chemistry chemical physics : PCCP.

[8]  C. Herrmann,et al.  Mechanism of GTPase-activity-induced self-assembly of human guanylate binding protein 1. , 2010, Journal of molecular biology.

[9]  Alfred Wittinghofer,et al.  Triphosphate structure of guanylate‐binding protein 1 and implications for nucleotide binding and GTPase mechanism , 2000, The EMBO journal.

[10]  James J. P. Stewart,et al.  Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters , 2012, Journal of Molecular Modeling.

[11]  Hiroshi Fujisaki,et al.  Minimum Free Energy Path of Ligand-Induced Transition in Adenylate Kinase , 2012, PLoS Comput. Biol..

[12]  W. C. Still,et al.  A Smart Monte Carlo Technique for Free Energy Simulations of Multiconformational Molecules. Direct Calculations of the Conformational Populations of Organic Molecules , 1995 .

[13]  D. Taramelli,et al.  Optimized Synthesis and Antimalarial Activity of 1,2‐Dioxane‐4‐carboxamides , 2014 .

[14]  Markus Sitzmann,et al.  Software and resources for computational medicinal chemistry. , 2011, Future medicinal chemistry.

[15]  Michael R. Shirts,et al.  Statistically optimal analysis of samples from multiple equilibrium states. , 2008, The Journal of chemical physics.

[16]  Stefano Piana,et al.  Demonstrating an Order-of-Magnitude Sampling Enhancement in Molecular Dynamics Simulations of Complex Protein Systems. , 2016, Journal of chemical theory and computation.

[17]  Alfred Wittinghofer,et al.  How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP , 2006, Nature.

[18]  W. Guba,et al.  A Real-World Perspective on Molecular Design. , 2016, Journal of medicinal chemistry.

[19]  Gregory L. Wilson,et al.  Integrating structure-based and ligand-based approaches for computational drug design. , 2011, Future medicinal chemistry.

[20]  David W. Ritchie,et al.  Comparison of Ligand-Based and Receptor-Based Virtual Screening of HIV Entry Inhibitors for the CXCR4 and CCR5 Receptors Using 3D Ligand Shape Matching and Ligand-Receptor Docking , 2008, J. Chem. Inf. Model..

[21]  G. Wondrak Redox-directed cancer therapeutics: molecular mechanisms and opportunities. , 2009, Antioxidants & redox signaling.

[22]  Baohua Ji,et al.  Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors. , 2009, The Journal of chemical physics.

[23]  K. Ingold,et al.  Kinetic applications of electron paramagnetic resonance spectroscopy. 35. The search for a dialkylaminyl rearrangement. Ring opening of N-cyclobutyl-N-n-propylaminyl , 1980 .

[24]  Martin Stahl,et al.  Small Molecule Conformational Preferences Derived from Crystal Structure Data. A Medicinal Chemistry Focused Analysis , 2008, J. Chem. Inf. Model..

[25]  N. Castagnoli,et al.  tert-Butoxyl as a model for radicals in biological systems: caveat emptor. , 2001, Journal of the American Chemical Society.

[26]  C. Herrmann,et al.  Nucleotide dependent cysteine reactivity of hGBP1 uncovers a domain movement during GTP hydrolysis , 2009, FEBS letters.

[27]  G. Scambia,et al.  Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking region. , 2008, Gene.

[28]  J. Zweier,et al.  The natural polyamine spermine functions directly as a free radical scavenger. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Friesner,et al.  Computing Redox Potentials in Solution: Density Functional Theory as A Tool for Rational Design of Redox Agents , 2002 .

[30]  Norman E. Davey,et al.  The switches.ELM Resource: A Compendium of Conditional Regulatory Interaction Interfaces , 2013, Science Signaling.

[31]  Ettore Novellino,et al.  Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors. , 2008, Journal of medicinal chemistry.

[32]  C. Clementi,et al.  Discovering mountain passes via torchlight: methods for the definition of reaction coordinates and pathways in complex macromolecular reactions. , 2013, Annual review of physical chemistry.

[33]  M. Tuckerman,et al.  Understanding Modern Molecular Dynamics: Techniques and Applications , 2000 .

[34]  O. Skorokhod,et al.  Oxidative stress-mediated antimalarial activity of plakortin, a natural endoperoxide from the tropical sponge Plakortis simplex. , 2015, Free radical biology & medicine.

[35]  M. Workentin,et al.  First Determination of the Standard Potential for the Dissociative Reduction of the Antimalarial Agent Artemisinin , 1998 .

[36]  Margaret A. Phillips,et al.  Identification of New Human Malaria Parasite Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors by Pharmacophore and Structure-Based Virtual Screening , 2016, J. Chem. Inf. Model..

[37]  E. Novellino,et al.  New anticancer agents mimicking protein recognition motifs. , 2013, Journal of medicinal chemistry.

[38]  V. Barone,et al.  Insight into the mechanism of action of plakortins, simple 1,2-dioxane antimalarials. , 2010, Organic & biomolecular chemistry.

[39]  Giovanni Scalmani,et al.  New developments in the polarizable continuum model for quantum mechanical and classical calculations on molecules in solution , 2002 .

[40]  U. Pischel,et al.  Switch-over in photochemical reaction mechanism from hydrogen abstraction to exciplex-induced quenching: interaction of triplet-excited versus singlet-excited acetone versus cumyloxyl radicals with amines. , 2001, Journal of the American Chemical Society.

[41]  A. Ianaro,et al.  Metabolites from the sponge Plakortis simplex. Determination of absolute stereochemistry of plakortin. Isolation and stereostructure of three plakortin related compounds , 1999 .

[42]  S. Parapini,et al.  Activity against Plasmodium falciparum of cycloperoxide compounds obtained from the sponge Plakortis simplex. , 2002, The Journal of antimicrobial chemotherapy.

[43]  Hiroshi Fujisaki,et al.  Extended Phase-Space Methods for Enhanced Sampling in Molecular Simulations: A Review , 2015, Front. Bioeng. Biotechnol..

[44]  M. Goheen,et al.  Influence of host iron status on Plasmodium falciparum infection , 2014, Front. Pharmacol..

[45]  C. W. Jefford New developments in synthetic peroxidic drugs as artemisinin mimics. , 2007, Drug discovery today.

[46]  P. Cresswell,et al.  Role of individual domains and identification of internal gap in human guanylate binding protein-1. , 2009, Journal of molecular biology.

[47]  J. Baker An algorithm for the location of transition states , 1986 .

[48]  S. Parapini,et al.  A new class of antimalarial dioxanes obtained through a simple two-step synthetic approach: rational design and structure-activity relationship studies. , 2011, Journal of medicinal chemistry.

[49]  G. Scuseria,et al.  Achieving linear-scaling computational cost for the polarizable continuum model of solvation , 2004 .

[50]  F. Turrini,et al.  Targeting the redox metabolism of Plasmodium falciparum. , 2013, Future medicinal chemistry.

[51]  G. Scambia,et al.  Looking at drug resistance mechanisms for microtubule interacting drugs: does TUBB3 work? , 2007, Current cancer drug targets.

[52]  W. Goddard,et al.  Atomic level simulations on a million particles: The cell multipole method for Coulomb and London nonbond interactions , 1992 .

[53]  E. Novellino,et al.  Manadoperoxides A-D from the Indonesian sponge Plakortis cfr. simplex. Further insights on the structure-activity relationships of simple 1,2-dioxane antimalarials. , 2010, Journal of natural products.

[54]  E. Novellino,et al.  GTP is an allosteric modulator of the interaction between the guanylate-binding protein 1 and the prosurvival kinase PIM1. , 2015, European journal of medicinal chemistry.

[55]  Timothy S. Ham,et al.  Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.

[56]  N. Grishin,et al.  PROMALS3D: a tool for multiple protein sequence and structure alignments , 2008, Nucleic acids research.

[57]  G. Scambia,et al.  Investigation of the Bcl-2 multimerisation process: structural and functional implications. , 2011, Biochimica et biophysica acta.

[58]  T. Shapiro,et al.  Molecular mechanisms of resistance in antimalarial chemotherapy: the unmet challenge. , 2005, Annual review of pharmacology and toxicology.

[59]  Jennifer L. Knight,et al.  Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. , 2015, Journal of the American Chemical Society.

[60]  N. Day,et al.  Artemisinin resistance: current status and scenarios for containment , 2010, Nature Reviews Microbiology.

[61]  Yuxiang Dong,et al.  Synthetic peroxides as antimalarials , 2004, Medicinal research reviews.

[62]  R. Dror,et al.  Long-timescale molecular dynamics simulations of protein structure and function. , 2009, Current opinion in structural biology.

[63]  G. Giannini,et al.  Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation. , 2011, Journal of medicinal chemistry.

[64]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[65]  S. Parapini,et al.  Marine inspired antiplasmodial thiazinoquinones: synthesis, computational studies and electrochemical assays , 2015 .

[66]  S. Parapini,et al.  Endoperoxide polyketides from a Chinese Plakortis simplex: further evidence of the impact of stereochemistry on antimalarial activity of simple 1,2-dioxanes. , 2014, Bioorganic & medicinal chemistry.

[67]  Y. Sugita,et al.  Replica-exchange molecular dynamics method for protein folding , 1999 .

[68]  J. Scaiano,et al.  Absolute rate constants for the reactions of tert-butoxyl, tert-butylperoxyl, and benzophenone triplet with amines: the importance of a stereoelectronic effect , 1981 .

[69]  D. Baltimore,et al.  Modular binding domains in signal transduction proteins , 1995, Cell.

[70]  C. Dumontet,et al.  Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents? , 2008, The Lancet. Oncology.

[71]  E. Callaway The revolution will not be crystallized: a new method sweeps through structural biology , 2015, Nature.

[72]  Diane Joseph-McCarthy,et al.  Ensemble-Based Docking Using Biased Molecular Dynamics , 2014, J. Chem. Inf. Model..

[73]  Evan Bolton,et al.  PubChem's BioAssay Database , 2011, Nucleic Acids Res..

[74]  Rafael C Bernardi,et al.  GSAFold: A new application of GSA to protein structure prediction , 2012, Proteins.

[75]  A. Becke Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[76]  A. Wittinghofer,et al.  Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins , 2000, Nature.

[77]  Martin Zacharias,et al.  Simulated annealing coupled replica exchange molecular dynamics--an efficient conformational sampling method. , 2009, Journal of structural biology.

[78]  Hsuan-Cheng Huang,et al.  Reviewing Ligand-Based Rational Drug Design: The Search for an ATP Synthase Inhibitor , 2011, International journal of molecular sciences.

[79]  Lewis E. Kay,et al.  New Tools Provide New Insights in NMR Studies of Protein Dynamics , 2006, Science.

[80]  A. Leach A Survey of Methods for Searching the Conformational Space of Small and Medium-Sized Molecules , 2007 .

[81]  Qigui Li,et al.  Toxicokinetic and toxicodynamic (TK/TD) evaluation to determine and predict the neurotoxicity of artemisinins. , 2011, Toxicology.

[82]  P. Dráber,et al.  Tubulins as therapeutic targets in cancer: from bench to bedside. , 2012, Current pharmaceutical design.

[83]  E. Martinelli,et al.  Class III β‐tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer , 2012, Journal of cellular physiology.

[84]  Ignacio E. Sánchez,et al.  The eukaryotic linear motif resource ELM: 10 years and counting , 2013, Nucleic Acids Res..

[85]  D. Koshland The Key–Lock Theory and the Induced Fit Theory , 1995 .

[86]  Anne Robert,et al.  From classical antimalarial drugs to new compounds based on the mechanism of action of artemisinin , 2001 .

[87]  M. Workentin,et al.  Kinetics of the photoinduced dissociative electron transfer reduction of the antimalarial endoperoxide, Artemisinin , 2001 .

[88]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[89]  Bin Liu,et al.  Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum , 2015, Nature Communications.

[90]  Edward W. Lowe,et al.  Computational Methods in Drug Discovery , 2014, Pharmacological Reviews.

[91]  Harvey T. McMahon,et al.  The dynamin superfamily: universal membrane tubulation and fission molecules? , 2004, Nature Reviews Molecular Cell Biology.

[92]  E. Novellino,et al.  From Protein Communication to Drug Discovery. , 2015, Current topics in medicinal chemistry.

[93]  G. Scambia,et al.  Class III β-tubulin (TUBB3): more than a biomarker in solid tumors? , 2011, Current molecular medicine.

[94]  D. Boehr,et al.  How Do Proteins Interact? , 2008, Science.

[95]  A. Cavalli,et al.  Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms. , 2015, Accounts of chemical research.

[96]  Klaus Schulten,et al.  Challenges in protein-folding simulations , 2010 .

[97]  P G Wolynes,et al.  Learning To Fold Proteins Using Energy Landscape Theory. , 2013, Israel journal of chemistry.

[98]  Pavel I Zhuravlev,et al.  Protein functional landscapes, dynamics, allostery: a tortuous path towards a universal theoretical framework , 2010, Quarterly Reviews of Biophysics.

[99]  R. Russell,et al.  Linear motifs: Evolutionary interaction switches , 2005, FEBS letters.

[100]  G. Tundo,et al.  Cationic porphyrins are tunable gatekeepers of the 20S proteasome† †Electronic supplementary information (ESI) available: It is reporting computational details, semi-log plots of residual CP activities, Molprobity results. See DOI: 10.1039/c5sc03312h , 2015, Chemical science.

[101]  Sandro Chiodo,et al.  Newly developed basis sets for density functional calculations , 2005, J. Comput. Chem..

[102]  E. Novellino,et al.  Identification of the First Inhibitor of the GBP1:PIM1 Interaction. Implications for the Development of a New Class of Anticancer Agents against Paclitaxel Resistant Cancer Cells , 2014, Journal of medicinal chemistry.

[103]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[104]  Charles H Reynolds,et al.  Impact of computational structure-based methods on drug discovery. , 2014, Current pharmaceutical design.

[105]  Eric J. Deeds,et al.  Understanding ensemble protein folding at atomic detail , 2006, Proceedings of the National Academy of Sciences.

[106]  U. Bandyopadhyay,et al.  Redox regulation in malaria: current concepts and pharmacotherapeutic implications. , 2012, Current medicinal chemistry.

[107]  D. Taramelli,et al.  Antimalarials based on the dioxane scaffold of plakortin. A concise synthesis and SAR studies. , 2011, Bioorganic & medicinal chemistry.

[108]  Alessandra Nurisso,et al.  How the flexibility of human histone deacetylases influences ligand binding: an overview. , 2015, Drug discovery today.

[109]  S. Teichmann,et al.  Probing the diverse landscape of protein flexibility and binding. , 2012, Current opinion in structural biology.

[110]  A. Laio,et al.  Escaping free-energy minima , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[111]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[112]  Chung F Wong,et al.  Flexible protein–flexible ligand docking with disrupted velocity simulated annealing , 2008, Proteins.

[113]  D. Taramelli,et al.  New antimalarial 3-methoxy-1,2-dioxanes: optimization of cellular pharmacokinetics and pharmacodynamics properties by incorporation of amino and N-heterocyclic moieties at C4 , 2015 .

[114]  Eric J. Martin,et al.  Conformational Sampling of Bioactive Molecules: A Comparative Study , 2007, J. Chem. Inf. Model..

[115]  E. Davioud‐Charvet,et al.  A physico-biochemical study on potential redox-cyclers as antimalarial and anti-schistosomal drugs. , 2012, Current pharmaceutical design.

[116]  Santosh A. Khedkar,et al.  Successful applications of computer aided drug discovery: moving drugs from concept to the clinic. , 2010, Current topics in medicinal chemistry.

[117]  C. W. Jefford Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action. , 2001, Current medicinal chemistry.

[118]  S. Parapini,et al.  Endoperoxide derivatives from marine organisms: 1,2-dioxanes of the plakortin family as novel antimalarial agents. , 2006, Journal of medicinal chemistry.

[119]  S. Parapini,et al.  Antimalarial Polyketide Cycloperoxides from the Marine SpongePlakortis simplex , 2005 .

[120]  Lorenz von Seidlein,et al.  Artemisinin resistance: current status and scenarios for containment , 2010, Nature Reviews Microbiology.

[121]  Rafael C. Bernardi,et al.  Enhanced sampling techniques in molecular dynamics simulations of biological systems. , 2015, Biochimica et biophysica acta.

[122]  B. Berne,et al.  Replica exchange with solute tempering: a method for sampling biological systems in explicit water. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[123]  G. Campiani,et al.  Paclitaxel directly binds to Bcl-2 and functionally mimics activity of Nur77. , 2009, Cancer research.

[124]  H. Misra,et al.  Hydroxyl radical scavenging and singlet oxygen quenching properties of polyamines , 2004, Molecular and Cellular Biochemistry.

[125]  C. Tsallis,et al.  Generalized simulated annealing , 1995, cond-mat/9501047.

[126]  Garland R. Marshall,et al.  The Conformational Parameter in Drug Design: The Active Analog Approach , 1979 .

[127]  D. S. Bohle,et al.  Orienting the heterocyclic periphery: a structural model for chloroquine's antimalarial activity. , 2014, Chemical communications.